Director, Regulatory Affairs, Establishment Group @ AVENTIS BEHRING (Marburg, GERMANY) (January 1998 - January 2001)
Associate Director, Drug Regulatory Affairs @ CENTEON, LLC (became Aventis Behring) (January 1995 - January 1998)
Regulatroy Affairs @ Cambridge Biotech (January 1991 - January 1995)
Operations Manager @ Endogen (January 1988 - January 1991)
Michael Vanderwerf Education
The Johns Hopkins University
MS (Biotechnology)
2007-2010
University of Minnesota
BA Biology (Evolutionary Biology/Genetics and Philosophy of Science)
1981-1986
Michael Vanderwerf Skills
Regulatory strategy
CMC problem solving
Regulatory Affairs
GMP
Life Sciences
Biotechnology
Vaccines
cGMP
Process Validation
Validation
Quality System
IND
FDA
Biologics
CAPA
Biopharmaceuticals
Regulatory Submissions
Infectious Diseases
CMC
Lifesciences
Technology Transfer
Pharmaceutics
CMC Regulatory Affairs
GLP
Sop
Drug Development
Medical Devices
Cell
eCTD
Technical Writing
Social Media
Global Regulatory Compliance
Sop Writing
FDA GMP
Sales
Quality Improvement
Regulatory Requirements
Clinical Trials
Molecular and Cellular Biology
Root Cause Analysis
Quality Assurance
Regulatory Compliance
u.s. Food and Drug Administration Fda
Microsoft Office
Customer Service
Quality Systems Design
Regulatory Analysis
Quality System Compliance
Regulatory
Pharmaceutical Industry
Software
u.s. Food and Drug Administration
Michael Vanderwerf Summary
Michael Vanderwerf, based in California, United States, is currently a Director, Regulatory Affairs at Organogenesis, Inc. Michael Vanderwerf brings experience from previous roles at Shire Regenerative Medicine, GlaxoSmithKline Biologicals, SAIC and AVENTIS BEHRING. Michael Vanderwerf holds a 2007 - 2010 MS in Biotechnology @ The Johns Hopkins University. With a robust skill set that includes Regulatory strategy, CMC problem solving, Regulatory Affairs, GMP, Life Sciences and more. Michael Vanderwerf has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Vanderwerf?
Find contact details for 700 million professionals.